These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 20737684)
1. [Effect of methods of application of bacterial ligands on activation of lymphoid organs' effectors in mice]. Akhmatova NK; Chertov IV; Akhmatov EA; Kurbatova EA; Egorova NB; Semenova IB Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):56-61. PubMed ID: 20737684 [TBL] [Abstract][Full Text] [Related]
2. [Expression of Toll-like receptors in spleen and lymphatic nodes after immunization by mucosal routes]. Akhmatova NK; Egorova NB; Akhmatov EA; Kurbatova EA; Semenova IB; Chertov IV; Semenov BF; Zverev VV Zh Mikrobiol Epidemiol Immunobiol; 2010; (1):50-4. PubMed ID: 20218346 [TBL] [Abstract][Full Text] [Related]
3. [Protective activity of Immunovac-VP-4 vaccine against avian influenza virus H5N2 administered by different methods]. Egorova NB; Kurbatova EA; Akhmatova NK; Semenova IB Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):49-53. PubMed ID: 21446167 [TBL] [Abstract][Full Text] [Related]
4. Activation of innate immunity by bacterial ligands of toll-like receptors. Akhmatova NK; Egorova NB; Kurbatova EA; Akhmatov EA Front Immunol; 2014; 5():89. PubMed ID: 24634669 [TBL] [Abstract][Full Text] [Related]
5. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally]. Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073 [TBL] [Abstract][Full Text] [Related]
6. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever]. Poddubikova AM; Kostinov MP Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399 [TBL] [Abstract][Full Text] [Related]
7. [Concept of inducing of rapid immunological protection against pathogens]. Semenov BF; Zverev VV Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):93-100. PubMed ID: 17882839 [TBL] [Abstract][Full Text] [Related]
8. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration]. Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947 [TBL] [Abstract][Full Text] [Related]
9. [Protective effect of the aerosol immunization of mice with the polycomponent vaccine Immunovac VP-4 after the challenge of the animals with Klebsiella pneumoniae virulent strain]. Solov'ev KG; Kurbatova EA; Egorova NB; Uspenskaia SN; Tret'iakova AV; Varfolomeev AN; Gruber IM; Efremova VN; Akhmatova NK; Diadizhshev NR; Akhmatova IB; Diadishchev NR; Semenova IB; Cherkasova LS; Semenov BF; Borovik RV Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):20-5. PubMed ID: 16532635 [TBL] [Abstract][Full Text] [Related]
10. [Immunovac-VP-4, immunomodulator decreases immunosuppression and enhances the cytotoxic activity induced by the cytostatic Cisplatin]. Akhmatova NK; Kiselevskiĭ MV; Kurbatova EA; Egorova NB; Semenov BF Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):44-8. PubMed ID: 15881938 [TBL] [Abstract][Full Text] [Related]
11. [Influence of various bacterial ligand application methods on cytokine expression]. Akhmanov ÈA; Utkina NP; Sorokina EA; Marakasova ES; Kurbatova EA; Lebedinskaia OV; Akhmatova NK Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):24-30. PubMed ID: 24738290 [TBL] [Abstract][Full Text] [Related]
12. [Dynamics of autoantibodies in elderly persons in the process of vaccination with Grippol and multicomponent vaccine VP-4]. Egorova NB; Semenov BF; Kurbatova EA; Iastrebova NE; Poddubikov AV; Efremova VN; Semenova IB Zh Mikrobiol Epidemiol Immunobiol; 2002; (5):29-35. PubMed ID: 12524997 [TBL] [Abstract][Full Text] [Related]
13. [An evaluation of the protective activity of a multicomponent vaccine made from opportunistic microorganisms in the oral method of immunization in a model of local staphylococcal infection]. Efremov VN; Poliachenko VM Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):73-6. PubMed ID: 8067121 [TBL] [Abstract][Full Text] [Related]
14. [Recombinant heat-shock protein (rHSP70) boosts activation of innate and adaptive immunity during simultaneous administration with bacterial antigens in experiment]. Shevchik IuS; Kurbatova EA; Sveshnikov PG; Akhmatova NK; Egorova NB Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):42-6. PubMed ID: 19338235 [TBL] [Abstract][Full Text] [Related]
15. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously]. Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974 [TBL] [Abstract][Full Text] [Related]
16. [Novel type of vaccine with a combination of Toll like receptor agonists--TLR 1/2, 4, 5/6, 9]. Egorova NB; Kurbatova EA; Gruber IM; Semenova IB; Mikhaĭlova NA; Zverev VV Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):40-6. PubMed ID: 21913390 [TBL] [Abstract][Full Text] [Related]
17. [Immunomodulators of microbial origin enhance cytotoxicity of human mononuclear leukocytes and reduce metastatic progression of Lewis lung carcinoma in mice]. Akhmatova NK; Semenova IB; Donenko FV; Kiselevskiĭ MV; Kurbatova EA; Egorova NB Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):35-40. PubMed ID: 17163136 [TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. Sasaki H; Ishikawa H; Kojima K; Itoh M; Matsumoto T; Itoh T; Hosomi O; Kawamoto E Vaccine; 2013 Nov; 31(48):5729-35. PubMed ID: 24091313 [TBL] [Abstract][Full Text] [Related]
19. [Influence of dendrite cells, generated with the use of immunomodulators of microbial origin, on the proliferative and cytotoxic activity of lymphocytes]. Akhmatova NK; Lebedinskaia OV; Kiselevskiĭ MV; Makashin AI; Semenova IB; Kurbatova EA; Egorova NB; Semenov BF Zh Mikrobiol Epidemiol Immunobiol; 2005; (6):38-42. PubMed ID: 16438373 [TBL] [Abstract][Full Text] [Related]
20. [Multicomponent vaccine VP-4 in the therapy of allergic diseases]. Osipova GL Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):36-42. PubMed ID: 12630351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]